OICHARTS
8 AMThe 8 AM report →

NEOCHEMNeochem Bio Solutions Limited share price

NSE · INE21UM01018 · 128 sessions on record
₹109.60▲ +1.10 · +1.0%from ₹108.50 the session before · 15 Oct 2026 close · NSE end of day
Open
₹111.90
High
₹111.90
Low
₹107.00
Day's range
₹4.94.5% of the previous close
VWAP
₹108.45close +1.1% from it
Volume, shares
42,0001.25× the 20-session average
Turnover, ₹ crore
0.46
Trades
172,500 shares per trade
Previous close
₹108.50+1.10 to the close
Price band, next session
₹98.65 – ₹120.5510% either side of the close · dynamic, widened in 5% steps when hit
Day range53% of the way up
₹107.00₹111.90
52-week range80% of the way up
₹63.00 30 Mar₹121.00 25 May

−9.4% from the high · +74% from the low

Futures and options

No derivatives listed on NEOCHEM

Close ₹ · Nifty 50 rebased to the first close · futures open interest by the day's build-up126 sessions to 15 Oct · axis fixed at 4 × ATR-14 around the last close
128 sessions on file · from 23 Dec
NEOCHEM close and futures open interest over the last 126 sessions, with Nifty 50 rebased to the first close63.2597.36131.48axis spans 108%Nifty 50NEOCHEM26 Dec9 Apr15 Oct126 sessions from 26 Dec to 15 Oct; the price axis spans 108 percent.

Quarterly results

standalone · latest filed 19 May, 05:07 pm IST · NSE filings

Revenue ₹111 cr; profit ₹12 cr in the Mar 2026 quarter, standalone.

Last 1 quarters, standalone₹ crore as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, Nifty 50 over the same session
Quarterly results of NEOCHEM on the standalone basis with the market's move on the first session after each filing
QuarterRevenue ₹ crRevenue YoYProfit ₹ crProfit YoYEPS ₹Market on the day
Mar 2026filed 19 May · audited₹111 cr—₹12 cr—8.71▲ +2.4%Nifty +0.2% · +2.2 pp

Fundamentals

standalone · filings to Mar 2026 · close ₹109.60 on 15 Oct

Fundamentals for NEOCHEM on the standalone basis to Mar 2026.

Valuationarithmetic on filings and the close · each cell names what it rests on · — where an input is missing
Market cap
—no NSE market-cap record yet
Price to earnings
—fewer than four consecutive quarters filed
Trailing EPS
—fewer than four consecutive quarters filed
Price to book
—no balance sheet filed yet
Book value a share
—no equity line in the filing
Debt to equity
—no equity line in the filing
Return on equity
—needs two filed balance sheets
Dividend yield
—no dividend with an ex-date in 365 days
Face value
—no NSE record yet
Shares outstanding
—no NSE record yet
Growthsums of the four quarters filed to Mar 2026 · growth against the four quarters before them · standalone
Revenue, trailing 12 months
—fewer than four consecutive quarters filed
Revenue growth, 12 months
—needs eight consecutive quarters filed
Revenue 3-year CAGR
—needs twelve consecutive quarters filed
Profit, trailing 12 months
—fewer than four consecutive quarters filed
Profit growth, 12 months
—needs eight consecutive quarters filed
Profit 3-year CAGR
—needs twelve consecutive quarters filed

Shareholding

quarter to 31 Mar · none pledged · NSE filings

Promoters hold 66.7%, foreign portfolio investors 0.2%, banks and financial institutions 15.8% and individual investors 12.0%, as filed for the quarter to 31 Mar.

By category, last 1 quarterspercent of shares · beneath each figure, the change in percentage points against the previous quarter on file
Shareholding of NEOCHEM by category over the last 1 quarters with the change against the previous quarter
Category31 Mar
Promoters66.72
Foreign portfolio investors0.18
Banks and financial institutions15.82
Individual investors12.03
Bodies corporate2.52
Others2.73

Corporate actions

NSE and BSE records

No corporate action on record for NEOCHEM yet.

Price history

128 sessions on record · to 15 Oct · NSE end of day

NEOCHEM is +4.2% over 20 sessions against Nifty's −0.5%, 9.4% below its 52-week high, realised volatility 54% annualised.

Returns against Nifty 50longest window first · Nifty 50 over the same sessions
Returns of the stock and Nifty 50 over six windows, longest first
WindowFrom ₹NEOCHEM %Nifty 50 %Difference pp
120 sessionssince 2 Jan₹84.45▲ +30%▼ −13%+42
60 sessionssince 13 Apr₹69.10▲ +59%▼ −3.5%+62
20 sessionssince 15 Sept₹105.15▲ +4.2%▼ −0.52%+4.8
5 sessionssince 8 Oct₹102.50▲ +6.9%▲ +3.4%+3.5
1 sessionsince 14 Oct₹108.50▲ +1.0%▲ +1.7%−0.65
Averages of the closeclose against each average
5-session average
₹107.01close +2.4% from it
20-session average
₹105.39close +4.0% from it
50-session average
₹98.89close +11% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
₹5.55.0% of the close
Average day's range, 20
₹4.94.5% of the close
Volume against 20 sessions
1.25×42,000 vs 29,000 average
Volatility and co-movement with Nifty 50annualised from daily log returns · counts share one denominator per cell
Realised volatility, 20
54%≈ ±3.4% a session · moved more than that on 4 of 20
Realised volatility, 60
68%≈ ±4.3% a session · moved more than that on 13 of 60
Beta to Nifty, 60
0.67moved with Nifty on 40 of 60 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
9 up · 11 downof 20
Last 60 sessions
30 up · 30 downof 60
Best session, 250
▲ +14%22 May
Worst session, 250
▼ −8.5%30 Dec

0 bulletins on NEOCHEM

The desk has not written about Neochem Bio Solutions Limited yet. The tape carries every bulletin as it is published.

About Neochem Bio Solutions Limited

exchange masters as of 18 Sept 2026 · classification by BSE
Company
Neochem Bio Solutions Limited
Exchange
NSE
ISIN
INE21UM01018
Sessions on record
128
Price source
NSE UDiFF bhavcopy · end of day · delayed
Filings
NSE and BSE public disclosures · results, shareholding and corporate actions as filed
Computed
15 Oct, 08:03 pm IST
Bulletins
0 · written by the desk · not a recommendation

OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.